BMC Gastroenterol

1. ANANCHUENSOOK P, Treeprasertsuk S, Komolmit P, Thanapirom K, et al
   Liver stiffness by non-invasive tests predicts hepatocellular carcinoma and liver-related complications following viral eradication with direct-acting antivirals in chronic hepatitis C: a retrospective cohort study.
   BMC Gastroenterol. 2026 May 14. doi: 10.1186/s12876-026-04920.
   

   >> Share

   
   

   
   Gut

2. CAO M, Wei F, Georges D, Alberts CJ, et al
   Hepatocellular carcinoma attributable to hepatitis B, hepatitis C and other risk factors at global, regional and national levels: an updated systematic review and meta-analysis.
   Gut. 2026 May 14:gutjnl-2025-337838. doi: 10.1136/gutjnl-2025-337838.
   

   >> Share

   
   

   
   J Infect Dis

3. GOYAL A, Cotler SJ, Matthews GV, Page K, et al
   Modeling predicts shortening of DAA treatment duration to 5 weeks in individuals with recent or chronic infection with HCV RNA negativity at day 7 on treatment.
   J Infect Dis. 2026 May 9:jiag260. doi: 10.1093.
   

   >> Share

   
   

   
   J Med Virol

4. CHANG SS, Liu CH, Chan SY, Lin LT, et al
   Hepatitis C Virus and Type 2 Diabetes: Mechanisms, Clinical Impact, and Post-DAA Management.
   J Med Virol. 2026;98:e70952.
   

   >> Share

   
   

   
   PLoS One

5. MARBAN-CASTRO E, Thomas C, Nikitin D, Thomas C, et al
   Key populations and healthcare providers perceptions, preferences and acceptability of HIV, Hepatitis B and C multiplex self-testing: A qualitative study.
   PLoS One. 2026;21:e0346601.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share